Breast cancer survivors and vitamin D: a review

Nutrition. 2010 Mar;26(3):255-62. doi: 10.1016/j.nut.2009.08.020. Epub 2009 Dec 8.

Abstract

Recent evidence has suggested a role for vitamin D in breast cancer prevention and survival. Studies have reported an inverse relation between vitamin D intake and the risk of breast cancer, improvements in survival after a diagnosis of breast cancer in women with higher levels of vitamin D, and vitamin D insufficiency in up to 75% of women with breast cancer. Preclinical data have indicated that vitamin D affects up to 200 genes that influence cellular proliferation, apoptosis, angiogenesis, terminal differentiation of normal and cancer cells, and macrophage function. Vitamin D receptors have been found in up to 80% of breast cancers, and vitamin D receptor polymorphisms have been associated with differences in survival. Although ongoing studies have investigated a possible link between adequate levels of vitamin D and improved cancer prognosis, breast cancer survivors may derive additional, non-cancer-related benefits from adequate vitamin D levels, including improvements in bone mineral density, quality of life, and mood. Maintaining adequate vitamin D stores is recommended for breast cancer survivors throughout their lifetime.

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Breast Neoplasms / prevention & control*
  • Female
  • Humans
  • Polymorphism, Genetic
  • Prognosis
  • Receptors, Calcitriol / genetics
  • Receptors, Calcitriol / metabolism*
  • Vitamin D / genetics
  • Vitamin D / therapeutic use*
  • Vitamin D Deficiency / complications*

Substances

  • Receptors, Calcitriol
  • Vitamin D